Diadema Partners LP
All holdings · as of Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| Alnylam Pharmaceuticals Inc | $2.12M | 1.3% |
| ELI LILLY & Co | $2.15M | 1.3% |
| Replimune Group, Inc. | $2.25M | 1.3% |
| CENTESSA PHARMACEUTICALS PLC | $2.25M | 1.3% |
| IRONWOOD PHARMACEUTICALS INC | $2.30M | 1.4% |
| IMMUNOCORE HOLDINGS PLC-ADRIMCR | $2.44M | 1.5% |
| Revolution Medicines, Inc. | $2.95M | 1.8% |
| Tenax Therapeutics, Inc. | $2.96M | 1.8% |
| CORCEPT THERAPEUTICS INC | $3.39M | 2.0% |
| BioAge Labs, Inc.BIOA | $3.59M | 2.1% |
| TG Therapeutics Inc | $3.68M | 2.2% |
| ANI PHARMACEUTICALS INC | $4.21M | 2.5% |
| VERTEX PHARMACEUTICALS INC / MA | $4.53M | 2.7% |
| CAPRICOR THERAPEUTICS, INC. | $4.56M | 2.7% |
| Cogent Biosciences, Inc. | $4.68M | 2.8% |
| United Therapeutics Corp | $4.87M | 2.9% |
| BridgeBio Pharma, Inc. | $5.35M | 3.2% |
| REGENERON PHARMACEUTICALS, INC. | $7.95M | 4.7% |
| BioMarin Pharmaceutical Inc | $8.70M | 5.2% |
| ABIVAX SA | $10.20M | 6.1% |
| Viking Therapeutics Inc | $11.85M | 7.1% |
| JOHNSON & JOHNSON | $13.75M | 8.2% |
| Terns Pharmaceuticals, Inc. | $13.97M | 8.3% |